These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88. The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation. Faerber L; Drechsler S; Ladenburger S; Gschaidmeier H; Fischer W Eur J Pharmacol; 2007 Mar; 560(1):1-8. PubMed ID: 17316606 [TBL] [Abstract][Full Text] [Related]
89. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions]. Tsukagoshi S; Ohta J; Taguchi T Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673 [TBL] [Abstract][Full Text] [Related]
90. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors. Costall B; Naylor RJ Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267 [TBL] [Abstract][Full Text] [Related]
91. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications]. Moulignier A Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037 [TBL] [Abstract][Full Text] [Related]
92. Pharmacological and anti-emetic properties of ondansetron. Tyers MB; Bunce KT; Humphrey PP Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S15-9. PubMed ID: 2533894 [TBL] [Abstract][Full Text] [Related]
93. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses? Montgomery SA; Fineberg N Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641 [TBL] [Abstract][Full Text] [Related]
97. The breadth of action of the 5-HT3 receptor antagonists. Costall B Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():3-9. PubMed ID: 8201244 [TBL] [Abstract][Full Text] [Related]
98. [Serotonin (5-HT)3 receptors: antagonists and their pharmacological profiles]. Miyata K; Honda K Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):143-52. PubMed ID: 7959407 [TBL] [Abstract][Full Text] [Related]